ES2119762T3 - Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas. - Google Patents

Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.

Info

Publication number
ES2119762T3
ES2119762T3 ES91302925T ES91302925T ES2119762T3 ES 2119762 T3 ES2119762 T3 ES 2119762T3 ES 91302925 T ES91302925 T ES 91302925T ES 91302925 T ES91302925 T ES 91302925T ES 2119762 T3 ES2119762 T3 ES 2119762T3
Authority
ES
Spain
Prior art keywords
treatment
prostaglandinas
ceto
waterfall
aid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91302925T
Other languages
English (en)
Spanish (es)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ES2119762T3 publication Critical patent/ES2119762T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES91302925T 1990-04-04 1991-04-03 Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas. Expired - Lifetime ES2119762T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9089590 1990-04-04
JP22164690 1990-08-22
JP2931091 1991-01-29

Publications (1)

Publication Number Publication Date
ES2119762T3 true ES2119762T3 (es) 1998-10-16

Family

ID=27286510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91302925T Expired - Lifetime ES2119762T3 (es) 1990-04-04 1991-04-03 Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.

Country Status (11)

Country Link
US (2) US5212324A (cg-RX-API-DMAC7.html)
EP (1) EP0453127B1 (cg-RX-API-DMAC7.html)
KR (1) KR970005172B1 (cg-RX-API-DMAC7.html)
AT (1) ATE169219T1 (cg-RX-API-DMAC7.html)
AU (1) AU644148B2 (cg-RX-API-DMAC7.html)
CA (1) CA2039420C (cg-RX-API-DMAC7.html)
DE (1) DE69129921T2 (cg-RX-API-DMAC7.html)
DK (1) DK0453127T3 (cg-RX-API-DMAC7.html)
ES (1) ES2119762T3 (cg-RX-API-DMAC7.html)
GR (1) GR3027666T3 (cg-RX-API-DMAC7.html)
TW (2) TW249226B (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW205508B (cg-RX-API-DMAC7.html) * 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH09505057A (ja) * 1993-11-19 1997-05-20 ザ・ユニバーシティ・オブ・シドニー 白内障を予防または制御するための方法
SE9403160D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab Method and means for prevention and treatment of secondary cataract
WO1997047595A1 (en) 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Endothelin antagonist
KR20010023839A (ko) * 1997-09-09 2001-03-26 데이비드 엠 모이어 Ｆｐ 작동약으로 유용한 방향족 ｃ16-ｃ20-치환된테트라히드로 프로스타글란딘
JP4619531B2 (ja) * 1997-09-09 2011-01-26 デューク ユニバーシティ Ｆｐアゴニストとして有用な、芳香族のあるｃ１６〜ｃ２０が置換されたテトラヒドロプロスタグランジン類
ES2310013T3 (es) * 1997-11-28 2008-12-16 Sucampo Ag Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
CN1350521A (zh) 1999-03-05 2002-05-22 宝洁公司 C16不饱和的fp选择性前列腺素类似物
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
JP2003526660A (ja) * 2000-03-16 2003-09-09 スカンポ・アクチェンゲゼルシャフト 高眼圧症および緑内障の治療
US6458836B1 (en) 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
AR030275A1 (es) 2000-03-24 2003-08-20 Sucampo Pharmaceuticals Inc Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
EP1267883B1 (en) * 2000-04-06 2009-06-17 Sucampo AG Bile secretion promoting composition for liver transplantation containing a 15-keto-prostaglandin
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
US20030060511A1 (en) * 2001-08-23 2003-03-27 Sucampo Ag Method for treatment of ocular hypertension and glaucoma
BR0212233A (pt) 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
US8580851B2 (en) * 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
ATE539756T1 (de) * 2002-10-23 2012-01-15 Sucampo Ag Prostaglandinsubstanzen für die behandlung von fettsucht
AU2003292556B2 (en) 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
KR20120005052A (ko) 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
AR055846A1 (es) 2005-01-27 2007-09-12 Sucampo Ag Compuesto de prostaglandina y metodo para tratar trastornos del sistema nervioso central
NZ561414A (en) * 2005-03-04 2010-10-29 Sucampo Ag Method and composition for treating peripheral vascular diseases
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
KR20140069182A (ko) * 2005-04-12 2014-06-09 수캄포 아게 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용
EP2682130A1 (en) * 2006-01-24 2014-01-08 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
NZ570191A (en) 2006-01-24 2010-09-30 R Tech Ueno Ltd Soft-gelatin capsule formulation comprising a keto-prostaglandin compound
CN103768070A (zh) 2006-03-13 2014-05-07 株式会社·R-技术上野 水性组合物
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
TW201247206A (en) 2011-04-07 2012-12-01 Sucampo Ag Method for treating asthenopia
NZ620300A (en) 2011-08-05 2015-09-25 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins
US3974195A (en) * 1974-10-02 1976-08-10 The Upjohn Company 2A,2B-Dihomo-15-alkyl-PGF2.sub.α analogs
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
EP0308135B1 (en) * 1987-09-18 1992-11-19 R-Tech Ueno Ltd. Ocular hypotensive agents
DE3873007T2 (de) * 1987-10-02 1992-12-03 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
EP0343904B1 (en) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia causing composition
AU604156B2 (en) * 1988-09-14 1990-12-06 R-Tech Ueno, Ltd. Prostaglandins of the F series
DE68918391T2 (de) * 1988-10-01 1995-01-19 Ueno Seiyaku Oyo Kenkyujo Kk Okulare hypotensive Mittel.
TW205508B (cg-RX-API-DMAC7.html) * 1990-08-02 1993-05-11 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo

Also Published As

Publication number Publication date
KR910018027A (ko) 1991-11-30
KR970005172B1 (ko) 1997-04-14
EP0453127B1 (en) 1998-08-05
DK0453127T3 (da) 1998-10-26
DE69129921T2 (de) 1999-01-14
DE69129921D1 (de) 1998-09-10
EP0453127A2 (en) 1991-10-23
US5686487A (en) 1997-11-11
CA2039420A1 (en) 1991-10-05
CA2039420C (en) 1996-12-10
AU7404791A (en) 1991-10-10
ATE169219T1 (de) 1998-08-15
TW249226B (cg-RX-API-DMAC7.html) 1995-06-11
GR3027666T3 (en) 1998-11-30
TW224942B (cg-RX-API-DMAC7.html) 1994-06-11
US5212324A (en) 1993-05-18
AU644148B2 (en) 1993-12-02
EP0453127A3 (en) 1992-12-09

Similar Documents

Publication Publication Date Title
ES2119762T3 (es) Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.
DE69122988D1 (de) Niederdruck-Spritzpistole
FI931364A7 (fi) Polyhydroxifettsyraamider i flytande tvaettmedelskompositioner som innehaoller blekmedel
FI881660A7 (fi) Foerfarande och anordning foer separering av gas med pumpen ur mediet som skall pumpas.
ES8600306A1 (es) Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos.
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
ATE83690T1 (de) Zerstaeubungspumpe.
DE69110516D1 (de) Stromversorgung.
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
ES2071169T3 (es) 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas.
FI912931A0 (fi) Benzopyranderivat och deras heterocykliska analoger som antiischemiska medel.
ATE104876T1 (de) Zerstaeubungspumpe.
NO894080L (no) Beleggsammensetninger.
FI920342L (fi) Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
ES2052850T3 (es) Un procedimiento para preparar un compuesto de hidrazona.
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
ES2052925T3 (es) Compuestos de pirazol, metodo para su produccion, su uso, y compuestos intermedios para la produccion de los mismos.
FI915643A0 (fi) Faktor som haemmar andningsutbraott.
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
ATE90195T1 (de) Minoxidil-gel.
ES2175228T3 (es) Metilsulfomicina i, un procedimiento para su produccion y su uso.
FI924088L (fi) Anvaendning av prostaglandin f3a som oegontryck saenkande medel
ES2108165T3 (es) Compuestos policiclicos 31668p y 31668u, un procedimiento para su produccion y su uso como agentes antibioticos o antitumorales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 453127

Country of ref document: ES